Azra Krek

Azra Krek

Auto-generated profile, based on publicly available information

Azra Krek

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2024 in Science Immunology
Verified
Journal Article
Closed access
PCPablo Canales-Herrerias
Pablo Canales-Herrerias
MUMathieu Uzzan
Mathieu Uzzan
ASAkihiro Seki
Akihiro Seki
RCRafael S. Czepielewski
Rafael S. Czepielewski
BVBram Verstockt
Bram Verstockt
SMSaurabh Mehandru
Saurabh Mehandru
Vedolizumab (VDZ) is a first-line treatment in ulcerative colitis (UC) that targets the α4β7- mucosal vascular addressin cell adhesion molecule 1 (MAdCAM-1) axis. To determine the mechanisms of action of VDZ, we examined five distinct cohorts of patients with UC. A decrease in naïve B and T cells in the intestines and gut-homing (β7 + ) plasmablasts in circulation of VDZ-treated patients suggested that VDZ targets gut-associated lymphoid tissue (GALT). Anti-α4β7 blockade in wild-type and photoconvertible (KikGR) mice confirmed a loss of GALT size and cellularity because of impaired cellular entry. In VDZ-treated patients with UC, treatment responders demonstrated reduced intestinal lymphoid aggregate size and follicle organization and a reduction of β7 + IgG + plasmablasts in circulation, as well as IgG + plasma cells and FcγR-dependent signaling in the intestine. GALT targeting represents a previously unappreciated mechanism of action of α4β7-targeted therapies, with major implications for this therapeutic paradigm in UC.

23 November 2015 in Genome Biology
Verified
Journal Article
Open access
PDF file
FRFranck Rapaport
Franck Rapaport
RKRaya Khanin
Raya Khanin
YLYupu Liang
Yupu Liang
MPMono Pirun
Mono Pirun
AKAzra Krek
Azra Krek
DBDoron Betel
Doron Betel

25 October 2024 in Science Immunology
Verified
Journal Article
Closed access
FCFrancesca Cossarini
Francesca Cossarini
JSJoan Shang
Joan Shang
AKAzra Krek
Azra Krek
ZAZainab Al-Taie
Zainab Al-Taie
RHRuixue Hou
Ruixue Hou
SMSaurabh Mehandru
Saurabh Mehandru
Gastrointestinal (GI) B cells and plasma cells (PCs) are critical to mucosal homeostasis and the host response to HIV-1 infection. Here, high-resolution mapping of human B cells and PCs sampled from the colon and ileum during both viremic and suppressed HIV-1 infection identified a reduction in germinal center (GC) B cells and follicular dendritic cells (FDCs) during HIV-1 viremia. Immunoglobulin A–positive (IgA + ) PCs are the major cellular output of intestinal GCs and were significantly reduced during viremic HIV-1 infection. PC-associated transcriptional perturbations, including type I interferon signaling, persisted in antiretroviral therapy (ART)–treated individuals, suggesting ongoing disruption of the intestinal immune milieu during ART. GI humoral immune perturbations were associated with changes in the intestinal microbiome composition and systemic inflammation. These findings highlight a key immune defect in the GI mucosa due to HIV-1 viremia.

20 May 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
FCFrancesca Cossarini
Francesca Cossarini
JSJoan Shang
Joan Shang
AKAzra Krek
Azra Krek
ZAZainab Al-Taie
Zainab Al-Taie
RHRuixue Hou
Ruixue Hou
SMSaurabh Mehandru
Saurabh Mehandru
Gastrointestinal (GI) B cells and plasma cells (PCs) are critical to mucosal homeostasis and the host response to HIV-1 infection. Here, high resolution mapping of human B cells and PCs sampled from the colon and ileum during both viremic and suppressed HIV-1 infection identified a reduction in germinal center (GC) B cells and follicular dendritic cells (FDCs) during HIV-1 viremia. IgA + PCs are the major cellular output of intestinal GCs and were significantly reduced during viremic HIV-1 infection. PC-associated transcriptional perturbations, including type I interferon signaling, persisted in antiretroviral therapy (ART)-treated individuals, suggesting ongoing disruption of the intestinal immune milieu during ART. GI humoral immune perturbations were associated with changes in the intestinal microbiome composition and systemic inflammation. These findings highlight a key immune defect in the GI mucosa due to HIV-1 viremia. One Sentence Summary: Intestinal germinal center B cell reduction in HIV-1 infection linked to reduced IgA + plasma cells and systemic inflammation.